acetylcysteine has been researched along with bryostatin 1 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, HW; Pettit, GR; Smith, JB; Smith, L; Vinitsky, A | 1 |
Lee, HW; Pettit, GR; Smith, JB; Smith, L | 1 |
Al-Katib, AM; Mohammad, RM; Reddy, KB; Wall, NR | 1 |
Grant, S; Vrana, JA | 1 |
4 other study(ies) available for acetylcysteine and bryostatin 1
Article | Year |
---|---|
Ubiquitination of protein kinase C-alpha and degradation by the proteasome.
Topics: Acetylcysteine; Adenosine Triphosphate; Amino Acid Sequence; Animals; Bryostatins; Cells, Cultured; Cysteine Endopeptidases; Cytosol; Down-Regulation; Hydrolysis; Isoenzymes; Lactones; Leucine; Macaca mulatta; Macrolides; Molecular Sequence Data; Multienzyme Complexes; Proteasome Endopeptidase Complex; Protein Kinase C; Protein Kinase C-alpha; Ubiquitins | 1996 |
Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts.
Topics: Acetylcysteine; Bryostatins; Cells, Cultured; Cysteine Proteinase Inhibitors; Down-Regulation; Fibroblasts; Glycoproteins; Humans; Isoenzymes; Lactones; Macrolides; Protein Kinase C; Protein Kinase C-alpha; Protein Kinase C-epsilon; Tetradecanoylphorbol Acetate; Ubiquitins | 1997 |
Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh.
Topics: Acetylcysteine; Antineoplastic Agents; Blotting, Northern; Blotting, Western; Bryostatins; Cell Extracts; Cysteine Endopeptidases; Humans; Lactones; Macrolides; Multienzyme Complexes; Precipitin Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Endopeptidase Complex; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Ubiquitins | 2000 |
Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade.
Topics: Acetylcysteine; Amanitins; Aminoacetonitrile; Apoptosis; Benzoquinones; Bryostatins; Butadienes; Curcumin; Cysteine Endopeptidases; Dactinomycin; Diterpenes; Drug Synergism; Enzyme Activation; Flavonoids; Humans; Imidazoles; Indoles; JNK Mitogen-Activated Protein Kinases; Lactams, Macrocyclic; Lactones; Macrolides; Maleimides; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Neoplasm Proteins; Nitriles; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein Kinase C; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-raf; Pyridines; Quinones; Terpenes; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Type C Phospholipases; U937 Cells; Ubiquitins | 2001 |